📰 Interested Persons News
Page 4 - Interested Persons News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Interested Persons. Real-time updates on events, politics, business and more.
July 8, 2022
DJ Charwood Energy: Success of Charwood Energy's Initial Public Offering on Euronext Growth® Paris Charwood Energy Charwood Energy: Success of Charwood Energy's Initial Public Offering on Euronext
May 27, 2022
Investegate announcements from Pure Gold Mining Inc, First Tranche of Private Placement Closed
May 26, 2022
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 25, 2022 (GLOBE...
May 6, 2022
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, British Columbia, May 06, 2022 (GLOBE...
August 28, 2021
A BUNCH of siblings have been left "devastated" and "stressed" after the inquest into the death of their mum was delayed.
February 16, 2021
(2) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy for the treatment of resistant and/or complicated bacterial infections, today announced that the United States Patent and Trademark Office (USPTO) has granted two patents for its anti-Pseudomonas Aeruginosa and Guy-Charles Fanneau de La Horie, CEO of Pherecydes Pharma, says: "We are very pleased that the USPTO has granted us these two new patents for our ...
February 2, 2021
Resounding Success of Pherecydes Pharmas IPO on the Euronext Growth Market in Paris Offer oversubscribed 4 times, with global demand totaling €28.1 million Capital increase of approximately €8 million, after full exercise of the Extension Clause Trading in the Companys shares begins on February 5, 2021 (FR0011651694 ALPHE) Regulatory News: Pherecydes Pharma (Paris:ALPHE) (FR0011651694 ALPHE), a biotechnology company specializing in precision phage therapy to treat resistant and/or complica...